AbCellera Biologics Inc. (ABCL) has 12 identified peers for comparison in the Healthcare sector. Peers include AVRO, CVAC, CWBR, HEPA, IOVA, KRYS and others.
ABCL has a market capitalization of $1.14B, compared to an average peer market cap of $3.1B. ABCL is notably smaller than its average peer.